Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Mackman

Showing results (371-380 of 397) with videos related to

Pageof 40
Sort By:
Blood Advances|January 15, 2020
Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factorSteven P Grover, Clare M Schmedes, Alyson C Auriemma, et al.
Immunity|May 12, 2019
Inflammasome Activation Triggers Blood Clotting and Host Death through PyroptosisCongqing Wu, Wei Lu, Yan Zhang, et al.
The Journal of Clinical Investigation|March 12, 2019
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1James V McCann, Lin Xiao, Dae Joong Kim, et al.
The Journal of Clinical Investigation|February 9, 2013
PAR-1 contributes to the innate immune response during viral infectionSilvio Antoniak, A Phillip Owens, Martin Baunacke, et al.
Blood|May 2, 2012
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancerJian-Guo Wang, Julia E Geddings, Maria M Aleman, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
The Journal of Clinical Investigation|February 24, 2015
RASA3 is a critical inhibitor of RAP1-dependent platelet activationLucia Stefanini, David S Paul, Raymond F Robledo, et al.
Oncotarget|March 12, 2016
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinomaDusten Unruh, Betül Ünlü, Clayton S Lewis, et al.
Blood|October 9, 2014
PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expressionM Bilal Iqbal, Michael Johns, Jun Cao, et al.
Nature Communications|September 1, 2025
Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysisAmelia K Haj, David S Paul, Sean J Jurgens, et al.
Pageof 40

Showing results (371-380 of 397) with videos related to

Sort By:
Pageof 40
Blood Advances|January 15, 2020
Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factorSteven P Grover, Clare M Schmedes, Alyson C Auriemma, et al.
Immunity|May 12, 2019
Inflammasome Activation Triggers Blood Clotting and Host Death through PyroptosisCongqing Wu, Wei Lu, Yan Zhang, et al.
The Journal of Clinical Investigation|March 12, 2019
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1James V McCann, Lin Xiao, Dae Joong Kim, et al.
The Journal of Clinical Investigation|February 9, 2013
PAR-1 contributes to the innate immune response during viral infectionSilvio Antoniak, A Phillip Owens, Martin Baunacke, et al.
Blood|May 2, 2012
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancerJian-Guo Wang, Julia E Geddings, Maria M Aleman, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
The Journal of Clinical Investigation|February 24, 2015
RASA3 is a critical inhibitor of RAP1-dependent platelet activationLucia Stefanini, David S Paul, Raymond F Robledo, et al.
Oncotarget|March 12, 2016
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinomaDusten Unruh, Betül Ünlü, Clayton S Lewis, et al.
Blood|October 9, 2014
PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expressionM Bilal Iqbal, Michael Johns, Jun Cao, et al.
Nature Communications|September 1, 2025
Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysisAmelia K Haj, David S Paul, Sean J Jurgens, et al.
Pageof 40